Clinical Drug Investigation

, Volume 38, Issue 6, pp 545–552 | Cite as

The Impact of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass on Intestinal Microbiota Differs from that of Laparoscopic Sleeve Gastrectomy in Japanese Patients with Obesity

  • Rieko Kikuchi
  • Junichiro Irie
  • Nobuko Yamada-Goto
  • Eri Kikkawa
  • Yosuke Seki
  • Kazunori Kasama
  • Hiroshi Itoh
Original Research Article


Background and Objectives

Bariatric surgery improves metabolic diseases and alters the intestinal microbiota in animals and humans, but different procedures reportedly have different impacts on the intestinal microbiota. We developed laparoscopic sleeve gastrectomy with duodenojejunal bypass (LSG-DJB) as an alternative to laparoscopic Roux-en-Y gastric bypass (LRYGB) in addition to laparoscopic sleeve gastrectomy (LSG) for Japanese patients with obesity. We investigated the precise change in the intestinal microbiota induced by these procedures in the present study.


A prospective observational study of 44 Japanese patients with obesity was conducted [22 patients underwent LSG, 18 underwent LSG-DJB, and 4 underwent laparoscopic adjustable gastric banding (LAGB)]. The patients’ clinical parameters and intestinal microbiota were investigated before and for 6 months after surgery. The microbiota was analyzed by a 16S rDNA method.


LSG and LSG-DJB significantly improved the metabolic disorders in the patients with obesity. The proportion of the phylum Bacteroidetes and order Lactobacillales increased significantly in the LSG group, and that of the order Enterobacteriales increased significantly in the LSG-DJB group.


LSG and LSG-DJB improved obesity and type 2 diabetes in Japanese patients with obesity, but the impact of LSG-DJB on the intestinal microbiota differed from that of LSG. This difference in the impact on the intestinal environment could explain the different efficacies of LSG and LSG-DJB in terms of their ability to resolve metabolic disorders in the clinical setting.


Author Contributions

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript. RK, JI, NYG, YS, KK, and HI designed the study. RK, JI, NYG, EK, and YS performed the study. RK, JI, and EK analyzed the data. RK, JI, YS, and HI wrote the manuscript. All authors participated in data interpretation, reviewed the manuscript, take responsibility for the integrity of the work as a whole, and approved the final version.

Compliance with Ethical Standards


This study was supported by research fellowships and grants from Keio University and AMED (17gm1010007h0001).

Ethical approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964, as revised in 2013.

Informed consent

Informed consent was obtained from all patients for being included in the study.

Conflict of interest

Rieko Kikuchi, Junichiro Irie, Nobuko Yamada-Goto, Eri Kikkawa, Yosuke Seki, Kazunori Kasama, and Hiroshi Itoh declare no conflict of interest.

Supplementary material

40261_2018_638_MOESM1_ESM.pdf (33 kb)
Supplementary material 1 (PDF 32 kb)


  1. 1.
    Cox LM, Blaser MJ. Pathways in microbe-induced obesity. Cell Metab. 2013;17:883–94.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Holmes E, Li JV, Marchesi JR, Nicholson JK. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 2012;16:559–64.CrossRefPubMedGoogle Scholar
  3. 3.
    Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(248–56):e5.Google Scholar
  4. 4.
    Rubino F, Nathan DM, Eckel RH, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39:861–77.CrossRefPubMedGoogle Scholar
  5. 5.
    Rubino F, R’Bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol. 2010;6:102–9.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Zhang H, DiBaise JK, Zuccolo A, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA. 2009;106:2365–70.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049–57.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Magouliotis DE, Tasiopoulou VS, Sioka E, Chatedaki C, Zacharoulis D. Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis. Obes Surg. 2017;27:1345–57.CrossRefPubMedGoogle Scholar
  9. 9.
    Liou AP, Paziuk M, Luevano JM Jr, Machineni S, Turnbaugh PJ, Kaplan LM. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med. 2013;5:178ra41.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22:228–38.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19:1341–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009;58:1400–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Seki Y, Kasama K, Umezawa A, Kurokawa Y. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for type 2 diabetes mellitus. Obes Surg. 2016;26:2035–44.CrossRefPubMedGoogle Scholar
  14. 14.
    Seki Y, Kasama K, Haruta H, et al. Five-year results of laparoscopic sleeve gastrectomy with duodenojejunal bypass for weight loss and type 2 diabetes mellitus. Obes Surg. 2017;27:795–801.CrossRefPubMedGoogle Scholar
  15. 15.
    Committee SG. SAGES guideline for clinical application of laparoscopic bariatric surgery. Surg Endosc. 2008;22:2281–300.CrossRefGoogle Scholar
  16. 16.
    Irie J, Kanno Y, Kikuchi R, et al. L-Carnitine improves gastrointestinal disorders and altered the intestinal microbiota in hemodialysis patients. Biosci Microbiota Food Health. 2017;36:11–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Nishimoto Y, Mizutani S, Nakajima T, et al. High stability of faecal microbiome composition in guanidine thiocyanate solution at room temperature and robustness during colonoscopy. Gut. 2016;65:1574–5.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Shiozaki A, Yoneda S, Yoneda N, et al. Intestinal microbiota is different in women with preterm birth: results from terminal restriction fragment length polymorphism analysis. PLoS One. 2014;9:e111374.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Emoto T, Yamashita T, Sasaki N, et al. Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. J Atheroscler Thromb. 2016;23:908–21.CrossRefPubMedGoogle Scholar
  20. 20.
    Nagashima K, Hisada T, Sato M, Mochizuki J. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol. 2003;69:1251–62.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Larsen N, Vogensen FK, van den Berg FW, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5:e9085.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004;70:7220–8.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology. 2002;148:257–66.CrossRefPubMedGoogle Scholar
  24. 24.
    Damms-Machado A, Mitra S, Schollenberger AE, et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015;2015:806248.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Huang X, Weng P, Zhang H, Lu Y. Remodeling intestinal flora with sleeve gastrectomy in diabetic rats. J Diabetes Res. 2014;2014:196312.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Murphy R, Tsai P, Jullig M, Liu A, Plank L, Booth M. Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg. 2017;27:917–25.CrossRefPubMedGoogle Scholar
  27. 27.
    Freedberg DE, Toussaint NC, Chen SP, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015;149(883–5):e9.Google Scholar
  28. 28.
    Jackson MA, Goodrich JK, Maxan ME, et al. Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016;65:749–56.CrossRefPubMedGoogle Scholar
  29. 29.
    Shao Y, Ding R, Xu B, et al. Alterations of gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in Sprague-Dawley rats. Obes Surg. 2017;27:295–302.CrossRefPubMedGoogle Scholar
  30. 30.
    Kong LC, Tap J, Aron-Wisnewsky J, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr. 2013;98:16–24.CrossRefPubMedGoogle Scholar
  31. 31.
    Zhang X, Wang Y, Zhong M, et al. Duodenal-jejunal bypass preferentially elevates serum taurine-conjugated bile acids and alters gut microbiota in a diabetic rat model. Obes Surg. 2016;26:1890–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome Med. 2016;8:67.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Dao MC, Everard A, Aron-Wisnewsky J, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426–36.CrossRefPubMedGoogle Scholar
  34. 34.
    Nishijima S, Suda W, Oshima K, et al. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res. 2016;23:125–33.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105–8.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Lee WJ, Almulaifi AM, Tsou JJ, Ser KH, Lee YC, Chen SC. Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015;11:765–70.CrossRefPubMedGoogle Scholar
  37. 37.
    Zachariah PJ, Chen CY, Lee WJ, et al. Compared to sleeve gastrectomy, duodenal-jejunal bypass with sleeve gastrectomy gives better glycemic control in T2DM patients, with a lower beta-cell response and similar appetite sensations: mixed-meal study. Obes Surg. 2016;26:2862–72.CrossRefPubMedGoogle Scholar
  38. 38.
    Forslund K, Hildebrand F, Nielsen T, et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature. 2015;528:262–6.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, School of MedicineKeio UniversityShinjukuJapan
  2. 2.Weight Loss and Metabolic Surgery Center, Yotsuya Medical CubeTokyoJapan
  3. 3.AMED-CREST, Japan Agency for Medical Research and DevelopmentTokyoJapan

Personalised recommendations